regulatory T cell therapy (Sonoma Biotherapeutics/Lyell Immunopharma)

N/A

Report date: 2025/03/20 09:57:55

Base Information

Drug Nameregulatory T cell therapy (Sonoma Biotherapeutics/Lyell Immunopharma)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunomodulatorsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonoma Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLyell Immunopharma IncSonoma Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A